Document

Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium

Department of Justice Antitrust Division Notice is hereby given that, on January 7, 2026, pursuant to section 6(a) of the National Cooperative Research and Production Act of 199...

Department of Justice
Antitrust Division

Notice is hereby given that, on January 7, 2026, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damage under specified circumstances. Specifically, CMTx Biotech, Inc., Kings Park, NY; Cyanvac LLC, Athens, GA; E&e Bioclub LLC, Indianapolis, IN; Huntsville, AL; EZ-A Consulting LLC, Bel Air, MD; Govsignals Inc. New York, NY; Inimmune Corp, Missoula, MT; Noble Supply & Logistics, LLC, Boston, MA; Physical Sciences Inc., Andover, MA; Research Triangle Institute, Durham, NC; Sustainable Advancement of Green Energy—Sage Pacific LLC, Kapolei, HI; and Synko Pharma Corp, Tarrytown, NY have been added as parties to this venture.

Also, Aldevron, L.L.C., Prairie Rose, ND; Amyris, Inc., Emeryville, CA; ( printed page 58712) Federal Resources Supply Company, LLC, Stevensville, MD; Flambeau Diagnostics LLC, Madison, WI; Foothold Labs INC, Olathe, KS; Goldbelt Hawk L.L.C., Newport News, VA; Nantcell, Inc., Culver City, CA; Itl LLC, Hampton, VA; Joint Research and Development LLC, Stafford, VA; Luna Labs USA LLC, Charlottesville, VA; Redwire Space Components, LLC, Marlborough, MA; and Saponiqx Inc., Lexington, MA, have withdrawn as parties to this venture.

No other changes have been made to either the membership or planned activity of the group research project. Membership in this group research project remains open, and MCDC intends to file additional written notifications disclosing all changes in membership.

On November 13, 2015, MCDC filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to section 6(b) of the Act on January 6, 2016 (81 FR 513).

The last notification was filed with the Department on October 1, 2025. A notice was published in the Federal Register pursuant to section 6(b) of the Act on January 20, 2026 (91 FR 2369).

Suzanne Morris,

Deputy Director Civil Enforcement Operations, Antitrust Division.

[FR Doc. 2026-19005 Filed 9-15-26; 8:45 am]

BILLING CODE P

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

91 FR 58711

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical CBRN Defense Consortium,” thefederalregister.org (September 16, 2026), https://thefederalregister.org/documents/2026-19005/notice-pursuant-to-the-national-cooperative-research-and-production-act-of-1993-medical-cbrn-defense-consortium.